Valuation: ArcticZymes Technologies ASA

Market Cap 965M 103M 91.39M 84.66M 76.98M 144M 9.72B 147M 1.02B 399M 5.08B 385M 377M 16.24B P/E 2026 *
61.6x
P/E 2027 * 35.4x
Enterprise Value 687M 72.94M 65.02M 60.23M 54.77M 103M 6.92B 104M 722M 284M 3.61B 274M 268M 11.55B EV / Sales 2026 *
4.9x
EV / Sales 2027 * 4.11x
Free-Float
82.59%
Yield 2026 *
-
Yield 2027 * -
1 day-3.32%
1 week-1.31%
Current month-7.35%
1 month-9.57%
3 months+0.27%
6 months-2.07%
Current year-8.25%
1 week 18.7
Extreme 18.7
20
1 month 18.7
Extreme 18.7
21.3
Current year 18.3
Extreme 18.3
26.6
1 year 18.3
Extreme 18.3
31.4
3 years 12.34
Extreme 12.34
43.2
5 years 12.34
Extreme 12.34
100
10 years 3.5
Extreme 3.5
114.4
Manager TitleAgeSince
Chief Executive Officer - 2023-09-17
Director of Finance/CFO 51 2014-09-30
Chief Tech/Sci/R&D Officer 43 -
Director TitleAgeSince
Chairman 64 2024-06-25
Director/Board Member 62 2024-06-25
Director/Board Member - -
Date Insider Type Main position Quantity % Market Cap. Importance
8/14/25 Buy

Director

2,852 0.0056%
6/4/25 Buy

Chief Operating Officer

3,400 0.0067%
5/14/25 Exercice

Chief Operating Officer

15,000 0.0294%
Change 5-day change 1-year change 3-year change Capi.($)
-3.32%-1.31%-34.83%-28.41% 103M
-1.33%+4.88%+54.50%+109.94% 1,106B
-0.69%-3.77%+31.35%+66.62% 612B
-0.96%+0.55%+23.13%+94.26% 500B
+0.24%+5.58%+33.98%+59.40% 367B
-1.59%-1.25%+69.39%+43.02% 354B
-0.40%+3.53%+19.17%+46.55% 286B
-0.37%+3.11%-1.26%+18.23% 256B
-1.75%+1.76%+42.21%+51.44% 230B
-2.00%+1.75%+24.64%+95.14% 190B
Average -1.22%+1.78%+26.23%+55.62% 390.02B
Weighted average by Cap. -0.98%+2.30%+37.84%+75.46%

Financials

2026 *2027 *
Net sales 140M 14.87M 13.26M 12.28M 11.17M 20.95M 1.41B 21.3M 147M 57.92M 737M 55.8M 54.63M 2.36B 160M 17.01M 15.17M 14.05M 12.77M 23.97M 1.61B 24.36M 169M 66.26M 843M 63.83M 62.5M 2.7B
Net income 15.66M 1.66M 1.48M 1.37M 1.25M 2.34M 158M 2.38M 16.47M 6.48M 82.42M 6.24M 6.11M 263M 27.28M 2.9M 2.58M 2.39M 2.18M 4.08M 275M 4.15M 28.7M 11.29M 144M 10.87M 10.65M 459M
Net Debt -279M -29.59M -26.37M -24.43M -22.21M -41.68M -2.81B -42.37M -293M -115M -1.47B -111M -109M -4.69B -306M -32.54M -29M -26.87M -24.43M -45.84M -3.08B -46.59M -322M -127M -1.61B -122M -120M -5.15B
Projected Income Statement - Annual - ArcticZymes Technologies ASA
Logo ArcticZymes Technologies ASA
Arcticzymes Technologies ASA is a Norway-based holding company providing support functions to the ArcticZymes AS subsidiary including distribution, administration, finance, Information Technology (IT) and quality assurance. As a life science company, Arcticzymes Technologies ASA is focused on the development, manufacturing, and commercialization of novel and high-quality recombinant enzymes for use in molecular research, In Vitro Diagnostics (IVD) and biomanufacturing. Some of the key features of the Company’s enzymes include cold activeness and salt tolerance. The Company’s divided into two operating segments; Enzymes and Corporate. Arcticzymes established logistic hubs in the United States and the Netherlands to serve its customers more efficiently.
Employees
51
Date Price Change Volume
26-10-19 NOK 18.90 -3.32% 76,771
26-10-16 NOK 19.55 +2.89% 132,280
26-10-15 NOK 19.00 -0.26% 23,778
26-10-14 NOK 19.05 -0.78% 36,190
26-10-13 NOK 19.20 +0.26% 47,089
Trader
Investor
Global
Quality
ESG MSCI
-
MarketScreener Ratings - ArcticZymes Technologies ASA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
18.90NOK
Average target price
28.00NOK
Spread / Average Target
+48.15%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - ArcticZymes Technologies ASA